2021

SCAI 2021 Virtual Scientific Sessions once again brought together the interventional cardiology community from around around the world. 

Program highlights included

  • Keynote lecturer Dr. Sanjay Gutpa, CNN's chief medical correspondent
  • 10 live cases from around the world, featuring new approaches to treating complex heart disease
  • Congenital, Coronary, Peripheral and Structural tracks
  • Late breaking clinical research
  • State-of-the-art satellite sessions, presented by experts from industry partners on the latest advances in interventional technology

We look forward to returning to a live event and welcoming you to Atlanta in 2022.  

940

Participants

105

Countries

10

Live Cases


 

Late-breaking scientific highlights at SCAI 2021 Virtual Scientific Sessions

LBCS Roundtable Discussion 1

Drs. Grines, Cox, Belford, Klein and Tabaza discuss: 

  • Update on the North American COVID-19 Myocardial Infarction (NACMI) Registry 
  • SCAI Shock Classification for Mortality Risk Stratification: Survey of Published Evidence  
  • Final Results From The National Cardiogenic Shock Initiative 
  • Establishing the Optimal Duration of DAPT After PCI in High-Risk TWILIGHT-like patients with Acute Coronary Syndrome 
LBCS Roundtable Discussion 2

Drs. Bailey, Garratt, Kim, Mavromatis, and Tabaza discuss: 

  • The Harmony Transcatheter Pulmonary Valve: 1-Year Outcomes from the Pivotal Trial and 30-Day Outcomes from the Continued Access Study
  • International experience of 10 zig Covered CP stent correction of Sinus Venosus ASD
  • Socioeconomic and Geographic Access to Novel Therapeutics: An Analysis of Growth in TAVR Programs
  • Comparison of the ISCHEMIA trial population to Patients undergoing PCI in US Practice: a CathPCI National Cardiovascular Data Registry (NCDR) Research to Practice (R2P) Initiative
  • Safety and Efficacy of the Second Generation Robotic-Assisted System for PCI: Final Results of the Multicenter PRECISION GRX Study

 

*2021 Recorded Sessions—Registrants Only

Registrants will have access to the 2021 Scientific Sessions presentations, abstracts, and exhibitor booths via the app for up to one-year post-meeting.


 

CME and Evaluations

Accreditation Statements and Credit Designations

Accreditation Statement

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

2021 Virtual Scientific Sessions

Credit Designation

SCAI designates this live activity for a maximum of 30.5 American Medical Association (AMA) Physician’s Recognition Award (PRA) Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM) MOC

Successful completion of this Continuing Medical Education (CME) activity, which includes participation in the evaluation component, enables the participant to earn up to 30.5 medical knowledge MOC points in ABIM’s MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

2021 Virtual Scientific Sessions, Congenital Heart Disease Program

Credit Designation

SCAI designates this live activity for a maximum of 14.25* AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM) MOC

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 14.25 MOC points in ABP’s MOC program. It is SCAI’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Target Audiences

SCAI 2021 Virtual Scientific Sessions is for the following members of the medical community:

  • Invasive, interventional, and general cardiologists as well as internal medicine and other physician specialists
  • Pediatricians specializing in congenital heart disease
  • Cardiology and interventional cardiology fellows-in-training
  • Cath lab nurse practitioners, physician assistants, nurses, technologists, radiologic technologists, and technicians
  • Hospital administrators and service-line managers
  • Quality improvement specialists

SCAI's Independent Content 

As a provider of continuing medical education through ACCME, it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities. All participating faculty, course directors, planning committee members, and staff are required to disclose to SCAI any relevant financial relationships. SCAI identifies relevant conflicts of interest and resolves them before the activity begins.

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection, and analysis.

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the Food and Drug Administration (FDA) at first mention and where appropriate in the content.

Successful Completion

Attend the virtual sessions and complete the evaluation. Once those two requirements are met, you will be able to obtain the appropriate credit and certificate. Contact education@scai.org with questions.


 

SCAI 2021 Virtual Scientific Sessions Supporters

SCAI 2021 Virtual Scientific Sessions were supported by:

Abbott

Cordis

AstraZeneca

Edwards Lifesciences

Biotronik

Medtronic

Boston Scientific

Terumo

Chiesi

W.L. Gore

Cook Medical

 

 

SCAI 2021 Virtual Scientific Sessions CME Satellites were supported by:

Abiomed

Getinge

Amarin Pharma, Inc.

Medtronic

Cardiovascular Systems, Inc.

Medtronic India

Chiesi

Philips

Edwards Lifesciences

Shockwave

GE Healthcare

Siemens

 

SCAI 2021 Virtual Scientific Sessions non-CME Satellites were supported by:

Janssen

 

SCAI 2021 Extended Web Series Satellites were supported by:

Boston Scientific

Penumbra

LivaNova

Terumo

Industry opportunities at SCAI 2022 Scientific Sessions

 

For more information about exhibits, satellite symposia, and sponsorship opportunities

please contact Sandy Hung at shung@scai.org

 

 

For more information about grant opportunities

please contact Eric Grammer at egrammer@scai.org